Tolerability of the Combination of Lapatinib and Trastuzumab in Adults Age 60 or Older With HER2 Positive Locally Advanced or Metastatic Breast Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Daneng Li, MD
City of Hope Medical Center
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
8 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- City of Hope Medical Center
Duarte, California, United States
- City of Hope Antelope Valley
Lancaster, California, United States
- South Pasadena Cancer Center
Pasadena, California, United States
- Roswell Park Cancer Institute
Buffalo, New York, United States
- Lineberger Comprehensive Cancer Center, University of North Carolina
Chapel Hill, North Carolina, United States
- Duke University Medical Center
Durham, North Carolina, United States
- Case Western Reserve University
Cleveland, Ohio, United States
- Thomas Jefferson University
Philadelphia, Pennsylvania, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 20 Apr 2011
- Primary completion
- 22 Feb 2018
- Completion
- 20 Apr 2027
- Last update posted
- 25 Jun 2026
- Registered enrollment
- 40
- Registry id
- NCT01273610
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.